









Markets
/
Stocks
/
nasdaq-airs
/

Airsculpt Technologies Inc

AIRS

2.270USD

+0.340+17.62%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

141.73MMarket Cap

LossP/E TTM



Airsculpt Technologies Inc

2.270

+0.340+17.62%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Airsculpt Technologies Inc

Currency: USD Updated: 2026-02-06

Key Insights

Airsculpt Technologies Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 56 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 6.50.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Airsculpt Technologies Inc's Score

Industry at a Glance

Industry Ranking

56 / 75

Overall Ranking

277 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Airsculpt Technologies Inc Highlights

StrengthsRisks

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). It operates through the direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

Overvalued

The company’s latest PE is -7.51, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 48.68M shares, decreasing 0.00% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 1.31K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 2.45.

Analyst Rating

Based on 3 analysts

Hold

Current Rating

6.500

Target Price

+236.79%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Airsculpt Technologies Inc is 6.25, ranking 64 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 34.99M, representing a year-over-year decrease of 17.76%, while its net profit experienced a year-over-year decrease of 57.48%.

Score

Industry at a Glance

Previous score

6.25

Change



Financials

5.39

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.50

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.86

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.21

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

5.28

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Airsculpt Technologies Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Airsculpt Technologies Inc is 7.02, ranking 39 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -7.51, which is -3131.69% below the recent high of 227.70 and -1282.21% above the recent low of -103.82.

Score

Industry at a Glance

Previous score

7.02

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 56/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Airsculpt Technologies Inc is 6.67, ranking 52 out of 75 in the Healthcare Providers & Services industry. The average price target is 6.50, with a high of 7.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

6.67

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Hold

Current Rating

6.500

Target Price

+236.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Airsculpt Technologies Inc

AIRS

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Airsculpt Technologies Inc is 6.70, ranking 45 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 3.08 and the support level at 1.66, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.29

Change

0.41

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.082

Sell

RSI(14)

42.494

Neutral

STOCH(KDJ)(9,3,3)

19.919

Neutral

ATR(14)

0.391

Low Volatility

CCI(14)

-124.800

Sell

Williams %R

71.228

Sell

TRIX(12,20)

0.249

Sell

StochRSI(14)

75.298

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.290

Sell

MA10

2.638

Sell

MA20

2.595

Sell

MA50

2.608

Sell

MA100

5.270

Sell

MA200

5.148

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Airsculpt Technologies Inc is 7.00, ranking 38 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 77.78%, representing a quarter-over-quarter decrease of 0.58%. The largest institutional shareholder is The Vanguard, holding a total of 1.15M shares, representing 1.84% of shares outstanding, with 79.60% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Vesey Street Capital Partners, L.L.C.

30.32M

Rollins (Aaron)

14.72M

Thrivent Asset Management, LLC

5.35M

+3.41%

SW Investment Management LLC

4.50M

Balyasny Asset Management LP

1.27M

+13.71%

The Vanguard Group, Inc.

Star Investors

782.54K

+10.80%

BlackRock Institutional Trust Company, N.A.

855.25K

+17.15%

National Bank of Canada

805.00K

Dean (Dennis R)

620.66K

+79.08%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Airsculpt Technologies Inc is 1.63, ranking 69 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 2.75. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Airsculpt Technologies Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.